The generalisability of the results of RCTs investigating NIV in COPD

K. Le Grice (London, United Kingdom), N. Shah (London, United Kingdom), C. Bunce (London, United Kingdom), A. Malhotra (London, United Kingdom)

Source: International Congress 2019 – Hot topics in noninvasive ventilation
Session: Hot topics in noninvasive ventilation
Session type: Poster Discussion
Number: 3699
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Le Grice (London, United Kingdom), N. Shah (London, United Kingdom), C. Bunce (London, United Kingdom), A. Malhotra (London, United Kingdom). The generalisability of the results of RCTs investigating NIV in COPD. 3699

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019



Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD
Source: International Congress 2017 – Management of COPD
Year: 2017


Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs)
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019



The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


New RCTs evaluating NIV in stable hypercapnic COPD
Source: International Congress 2015 – Long-term non-invasive ventilation (NIV) in COPD
Year: 2015



The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




Variation in ventilation management and outcome in ICU patients without ARDS – an IPD metaanalysis of 4 worldwide observational studies
Source: Virtual Congress 2020 – New insights into mechanical ventilation in the intensive care unit
Year: 2020




NIV after acute exacerbation of COPD: results from the Dutch multicentre study
Source: International Congress 2015 – Long-term non-invasive ventilation (NIV) in COPD
Year: 2015



Measuring bronchodilation in COPD clinical trials
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004

COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression
Source: ERJ Open Res, 8 (1) 00261-2021; 10.1183/23120541.00261-2021
Year: 2022



DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021


ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



Methodological issues in therapeutic trials of COPD
Source: Eur Respir J 2008; 31: 927-933
Year: 2008



Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006